Vicarious Surgical (RBOT) Free Cash Flow (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Free Cash Flow came in at -$10.4 million in Q3 2025, up 17.44% year-on-year from -$8.9 million in Q3 2024, and up 22.91% on a QoQ basis from -$13.6 million in Q2 2025.
Vicarious Surgical (RBOT) Free Cash Flow (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Free Cash Flow data on file, last reported at -$10.4 million in Q3 2025.
- On a quarterly basis, Free Cash Flow rose 17.44% year-over-year to -$10.4 million in Q3 2025; TTM through Dec 2025 was -$35.8 million, a 28.34% increase from a year earlier, with the FY2024 full-year figure at -$49.9 million, up 22.01% from the prior year.
- Free Cash Flow for Q3 2025 stood at -$10.4 million, up from -$13.6 million in the prior quarter.
- Over the last five years, Free Cash Flow for RBOT reached as high as -$4.3 million in Q1 2021 and fell as low as -$18.9 million in Q1 2023.
- Historically, Free Cash Flow has averaged -$12.9 million across 5 years, with a median of -$12.7 million in 2024.
- Across the five-year window, Free Cash Flow slumped 3845.99% in 2021 and surged 32.79% in 2023, its largest moves.
- Year by year, Free Cash Flow stood at -$10.6 million in 2021, then slumped by 73.83% to -$18.5 million in 2022, then jumped by 32.79% to -$12.4 million in 2023, then grew by 5.4% to -$11.7 million in 2024, then advanced by 10.98% to -$10.4 million in 2025.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$10.4 million in Q3 2025, -$13.6 million in Q2 2025, and -$11.8 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.45 Mn |
| Sep 30, 2025 | -10.45 Mn |
| Jun 30, 2025 | -13.56 Mn |
| Jun 30, 2025 | -13.56 Mn |
| Mar 31, 2025 | -11.75 Mn |
| Mar 31, 2025 | -11.75 Mn |
| Dec 31, 2024 | -11.74 Mn |
| Dec 31, 2024 | -11.74 Mn |
| Sep 30, 2024 | -12.66 Mn |
| Sep 30, 2024 | -12.66 Mn |
| Jun 30, 2024 | -11.05 Mn |
| Jun 30, 2024 | -11.05 Mn |
| Mar 31, 2024 | -14.45 Mn |
| Mar 31, 2024 | -14.45 Mn |
| Dec 31, 2023 | -12.41 Mn |
| Dec 31, 2023 | -12.41 Mn |
| Sep 30, 2023 | -17.40 Mn |
| Sep 30, 2023 | -17.40 Mn |
| Jun 30, 2023 | -15.29 Mn |
| Jun 30, 2023 | -15.29 Mn |